Induction of protective immunity against microbial challenge by targeting antigens expressed by probiotic bacteria to mucosal dendritic cells

Current HIV Research

Volumn 8, Issue 4, 2010, Pages 323-329

  Mohamadzadeh, Mansour ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adjuvants; Dendritic cells; Macrophages; T regulatory cells; Vaccine

Indexed keywords

ADJUVANT; BACTERIAL ANTIGEN; PROBIOTIC AGENT;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; LACTOBACILLUS; MICROBIAL IMMUNITY; MUCOSA CELL; NONHUMAN;

ANTIBODY FORMATION; ANTIGENS; DENDRITIC CELLS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNITY, MUCOSAL; LACTOBACILLUS; MODELS, BIOLOGICAL; PROBIOTICS; T-LYMPHOCYTES;

EID: 77953503074     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791208668     Document Type: Article

References (59)

1. Acheson DW, Luccioli S. Microbial-gut interactions in health and disease. Mucosal immune responses. Best Pract Res Clin Gastroenterol 2004; 18: 387-404.
2. Acheson DWK, Luccioli S. Mucosal immune responses. Best Practice & Research Clin Gastroent 2004; 18: 387-404.
3. Niedergang F, Kweon MN. New trends in antigen uptake in the gut mucosa. Trends Microbiol 2005; 13: 485-90.
4. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006; 311: 1-16.
5. Sierro F, Dubois B, Coste A, et al. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 2001; 98: 13722-7.
6. Iliev ID, Matteoli G, Rescigno M. The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J Exp Med 2007; 204: 2253-7.
7. Akira S. Toll-like receptors and innate immunity. Adv Immunol 2001; 78: 1-56.
8. Kraehenbuhl JP, Corbett M. Immunology. Keeping the gut microflora at bay. Science 2004; 303: 1624-5.
9. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2: 361-7.
10. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med 1996; 183: 237-47.
11. Niess JH, Brand S, Gu X, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005; 307: 254-8.
12. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303: 1662-5.
13. Ngan J, Kind LS. Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol 1978; 120: 861-5.
14. Sun, CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775-85.
15. Johansson-Lindbom B, Agace WW. Vitamin A helps gut T cells find their way in the dark. Nat Med 2004; 10: 1300-1.
16. Johansson-Lindbom B, Agace WW. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol Rev 2007; 215: 226-42.
17. Johansson-Lindbom B, Svensson M, Pabst O, et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med 2005; 202: 1063-73.
18. Johansson-Lindbom B, Svensson M, Wurbel MA, et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 2003; 198: 963-9.
19. Denning TL, Wang YC, Patel SR, et al. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 2007; 8: 1086-94.
20. Ivins BE, Welkos SL, Little SF, et al. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect Immun 1992; 60: 662-8.
21. Ivins, BE, Pitt ML, Fellows PF, et al. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine 1998; 16: 1141-8.
22. Klinman DM. CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine. Expert Rev Vaccines 2006; 5: 365-9.
23. Klinman DM. Adjuvant activity of CpG oligodeoxynucleotides. Int Rev Immunol 2006; 25: 135-54.
24. Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines 2003; 2: 205-17.
25. Plant A, Williams NA. Modulation of the immune response by the cholera-like enterotoxins. Curr Top Med Chem 2004; 4: 509-19.
26. Holmgren J, Czerkinsky C, Eriksson K, et al. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 2003; 21: S89-95.
27. Schoen C, Stritzker J, Goebel W, Pilgrim S. et al. Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol 2004; 294: 319-35.
28. Vajdy M, Srivastava I, Polo J, Donnelly J, O'Hagan D, Singh M. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. Immunol Cell Biol 2004; 82: 617-27.
29. Makarova KS, Koonin EV. Evolutionary genomics of lactic acid bacteria. J Bacteriol 2007; 189: 1199-208.
30. Pfeiler EA, Azcarate-Peril MA, Klaenhammer TR. Characterization of a novel bile-inducible operon encoding a two- component regulatory system in Lactobacillus acidophilus. J Bacteriol 2007; 189: 4624-34.
31. Pfeiler EA, Klaenhammer TR. The genomics of lactic acid bacteria. Trends Microbiol 2007; 15: 546-53.
32. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003; 189: 1202-8.
33. Klaenhammer TR, Barrangou R, Buck BL, Azcarate-Peril MA, Altermann E.Genomic features of lactic acid bacteria effecting bioprocessing and health. FEMS Microbiol Rev 2005; 29: 393-409.
34. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. October 2001.
35. Roberts M, Chatfield S, Pickard D, Li J, Bacon A. Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors. Infect Immun 2000; 68: 6041-3.
36. Stevenson A, Roberts M. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. FEMS Immunol Med Microbiol 2003; 37: 121-8.
37. Saklani-Jusforgues H, Fontan E, Soussi N, Milon G, Goossens PL. Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope. Infect Immun 2003; 71: 1083-90.
38. Pouwels PH, Leer RJ, Shaw M, et al. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol 1998; 41: 155-67.
39. Wells JM, Robinson K, Chamberlain LM, Schofield KM, Le Page RW. Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek 1996; 70: 317-30.
40. Hanniffy S, Wiedermann U, Repa A, et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol 2004; 56: 1-64.
41. Mohamadzadeh M, Duong T, Hoover T, Klaenhammer TR. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev Vaccines 2008; 7: 163-74.
42. Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci USA 2009; 106: 4331-6.
43. Grangette C, Müller-Alouf H, Geoffroy M, Goudercourt D, Turneer M, Mercenier A. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 2002; 20: 3304-9.
44. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64: 5403-5.
45. Marin ML, Tejada-Simon MV, Lee JH, Murtha J, Ustunol Z, Pestka JJ. Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J Food Prot 1998; 61: 859-64.
46. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168: 171-8.
47. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003; 9: 175-91.
48. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009; 179: 186-93.
49. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10: 55-63.
50. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-4.
51. Goh YJ, Azcárate-Peril MA, O'Flaherty S, et al. Development and application of a upp-based counterselective gene replacement system for the study of the S-layer protein SlpX of Lactobacillus acidophilus NCFM. Appl Environ Microbiol 2009; 75: 3093-105.
52. Goh YJ, Klaenhammer TR. Genomic features of Lactobacillus species. Front Biosci 2009; 14: 1362-86.
53. Konstantinov SR, Smidt H, de Vos WM, et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci USA 2008; 105: 19474-9.
54. Crowe SR, Miller SC, Brown DM, et al. Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 2006; 24: 457-67.
55. Crowe SR, Miller SC, Woodland DL. Identification of protective and non-protective T cell epitopes in influenza. Vaccine 2006; 24: 452-6.
56. Kohlmeier JE, Miller SC, Smith J, et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 2008; 29: 101-13.
57. Zhong W, Reche PA, Lai CC, Reinhold B, Reinherz EL. Genome- wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J Biol Chem 2003; 278: 45135-44.
58. Russell WM, Klaenhammer TR. Identification and cloning of gusA, encoding a new beta-glucuronidase from Lactobacillus gasseri ADH. Appl Environ Microbiol 2001; 67: 1253-61.
59. Altermann E, Russell WM, Azcarate-Peril MA, et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc Natl Acad Sci USA 2005; 102: 3906-12.